The role of CCL5 has been described by our group in the formation of linearized breast cancer collagen, and while there is more confirmatory work to be done, blocking CCL5 presents a logical first step towards the goal of limiting triple-negative breast tumor evolution. The gene discussed is CCL5; the disease is breast carcinoma.